NCI/NIH-Sponsored Sessions

NIH Grants: Changes in Review and Funding Opportunities

Moderator: Suresh Mohla, National Cancer Institute, Bethesda, MD

Elaine Sierra-Rivera, Center for Scientific Review, Bethesda, MD
Suresh Mohla, National Cancer Institute, Bethesda, MD

NCI Supported Extramural Research Training and Career Development Opportunities: Which Are Best for My Career Path?

Lester S. Gorelic, National Cancer Institute, Rockville, MD
Sonia B. Jakowlew, National Cancer Institute-OCTR, Bethesda, MD
Shannon M. Lemrow, National Cancer Institute, Bethesda, MD
Nancy C. Lohrey, National Cancer Institute, Bethesda, MD
Dorkina Myrick, National Cancer Institute, Rockville, MD
Jonathan S. Wiest, National Cancer Institute, Bethesda, MD

Cancer Biomedical Informatics Grid® (caBIG®) Resources to Support Life Sciences and Translational Research

Moderator: Leslie K. Derr, National Cancer Institute, Rockville, MD

caBIG® overview
Juli Klemm, National Cancer Institute, Rockville, MD

Life sciences data and tools connected via caGrid
Juli Klemm, National Cancer Institute, Rockville, MD

caIntegrator 2: Integrative analysis of translational research data
Mervi A. Heiskanen, National Cancer Institute, Rockville, MD

caBIG® adoption at the Jackson Laboratory
Charles Donnelly, Jackson Laboratory, Bar Harbor, ME

Funding for Innovative Cancer Research: Support for Small Businesses from the NCI SBIR and STTR Programs

Michael Weingarten, National Institutes of Health, Bethesda, MD

Cancer Diagnostics Using Nanotechnology Platforms

Piotr Grodzinski, National Cancer Institute, Bethesda, MD
Michael J. Cima, Massachusetts Institute of Technology, Cambridge, MA
Joseph M. DeSimone, University of North Carolina, Chapel Hill, NC
James R. Heath, California Institute of Technology, Pasadena, CA
Chad A. Mirkin, Northwestern University, Evanston, IL
Ralph Weissleder, Massachusetts General Hospital, Charlestown, MA

Glycomics for Detection of Cancer and Cancer Risk

Introduction to NCI’s glycomics initiative
Sudhir Srivastava, National Cancer Institute, Rockville, MD

Introduction to tumor glycome laboratories
Karl Krueger, National Cancer Institute, Rockville, MD

Detection of autoantibodies and glycosylation variants in the diagnosis of pancreatic cancer
Michael A. Hollingsworth, University of Nebraska, Omaha, NE

Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma
Anand S. Mehta, Drexel University College of Medicine, Philadelphia, PA

Anti-Neu5Gc antibodies as a potential cancer biomarker
Richard Schwab, University of California, San Diego, La Jolla, CA

NCI Early Detection Research Network: Investment in Biomarker Research

Moderator: Sudhir Srivastava, National Cancer Institute, Rockville, MD

State of the EDRN
Sudhir Srivastava

Collaborative opportunity in EDRN
David Sidransky, Johns Hopkins Medical Institutes, Baltimore, MD

Re-issuance of EDRN
Sudhir Srivastava

NIH Grant Process and Opportunities for Cancer Research Funding at NIH

Chairperson: Phuong Kim Pham, National Cancer Institute, Bethesda, MD

Panelists
• Syed Musaddaq Quadri, IRG/CSR, Bethesda, MD
• Maria Agelli, National Cancer Institute, Bethesda, MD
• Christopher Hatch, National Cancer Institute, Bethesda, MD
• Nancy C. Lohrey, National Cancer Institute, Bethesda, MD

Speakers
• Caroline H. Dilworth, National Institute of Environmental Health Sciences, Durham, NC
• Jane W. Fountain, National Institute of Neurological Disorders and Strokes, Bethesda, MD
• Nancy L. Di Fronzo, National Institutes of Health, Bethesda, MD
• Pamela A. Marino, National Institutes of Health, NIGMS, Bethesda, MD
• Phuong Kim Pham
• Aron Primack, FIC, Bethesda, MD
• Helen Quill, National Institute of Allergy and Infectious Diseases, Bethesda, MD
• Yasaman Shirazi, NIDCR, Bethesda, MD
• William Timmer, National Cancer Institute, Rockville, MD
• Patricia W. Carolan, National Cancer Institute, Bethesda, MD

Translating Knowledge from the Cancer Genome Atlas (TCGA) to Understand and Control Cancer

Daniela Gerhard, National Cancer Institute, Bethesda, MD
Peter J. Park, Children’s Hospital, Harvard Medical School, Boston, MA
Ingo Mellinghof, Memorial Sloan-Kettering Cancer Center, New York, NY
Paul T. Spellman, Lawrence Berkeley National Laboratory, Berkeley, CA
Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY
David B. Agus, University of Southern California, Los Angeles, CA
Anna D. Barker, National Cancer Institute, Bethesda, MD

Using Cancer Genome Data Sets in Next Generation Cancer Research: Accessing and Analyzing TCGA and Other Large Scale Genomic Data

Using cancer genome data sets to examine mechanisms, targets, and outcomes in cancer
Kenneth H. Buetow, National Cancer Institute, Rockville, MD

The application of the Cancer Genome Workbench for analysis of TCGA and TARGET data
Jinghui Zhang, National Cancer Institute, Rockville, MD

The CMA portal: Analytical tools for large data sets
Juli Klemm, National Cancer Institute, Rockville, MD

Searching and downloading cancer genome data sets through TCGA Data Portal Data Access Matrix
Carl Schaefer, National Cancer Institute, Bethesda, MD

Technology Transfer: Financial and Career Opportunities for Cancer Researchers

Chairperson: Phuong Kim Pham, National Cancer Institute, Bethesda, MD

Kai Chen, IOMAI Corporation, Gaithersburg, MD
Gregory A. Curt, AstraZeneca Pharmaceuticals LP, Garritt Park, MD
Carol Stratford, KaloBios Pharmaceuticals, Inc., San Francisco, CA
Eric Hale, National Cancer Institute, Bethesda, MD
Phuong Kim Pham

DOD/CDMRP-Sponsored Session: Department of Defense Funding Opportunities for Cancer Research

E. Melissa Kaime, Congressionally Directed Medical Research Programs, Frederick, MD
Frances M. Visco, National Breast Cancer Coalition, Washington, DC
Carolyn J. Best, Congressionally Directed Medical Research Programs, Frederick, MD
Michael V. Seiden, Fox Chase Cancer Center, Philadelphia, PA
Douglas G. McNeel, University of Wisconsin, Madison, WI
Theresa J. Miller, Congressionally Directed Medical Research Program, Frederick, MD